Learn more

REHOVOT RES PROD

Overview
  • Total Patents
    26
About

REHOVOT RES PROD has a total of 26 patent applications. Its first patent ever was published in 1974. It filed its patents most often in Germany, Israel and United States. Its main competitors in its focus markets biotechnology, chemical engineering and macromolecular chemistry and polymers are STRAUCH & SCHMIDT, GLOBAL ALGAE INNOVATIONS INC and SHEVITZ JERRY.

Patent filings in countries

World map showing REHOVOT RES PRODs patent filings in countries

Patent filings per year

Chart showing REHOVOT RES PRODs patent filings per year from 1900 to 2020

Top inventors

# Name Total Patents
#1 Perry Mordechai 5
#2 Linder Charles 5
#3 Aviv Gershon 4
#4 Mordechai Perry 4
#5 Bloch Rene Dr 3
#6 Rubinstein Menachem 3
#7 Kedem Ora 3
#8 Ora Kedem 3
#9 Bloch Rene 2
#10 Bloch R 2

Latest patents

Publication Filing date Title
EP0135630A1 Amidoxime derivatives, processes for the preparation thereof and uses therefor
CA1198696A Amidoxime derivatives, processes for the preparation thereof and uses therefor
DK425083D0 Amidoxime derivatives, procedures for preparing these and use thereof
US4413999A Amidoxime derivatives, processes for the preparation
DE2907450A1 Essential amino acids e.g. L-tryptophan sepn. - from derivs. e.g. ester(s) by electrodialysis at ph 4-8
DE2907451A1 Non-essential aminoacid(s) e.g. phenyl-glycine, separation - from derivatives e.g. ester(s), by electrodialysis at pH 4-8
US4238307A Electrodialysis process for the separation of essential amino acids from derivatives thereof
US4238306A Electrodialysis process for the separation of non-essential amino acids from derivatives thereof
US4251631A Cross-linked enzyme membrane
DE2855775A1 METHOD AND DEVICE FOR PERFORMING A SELECTIVE ELECTRODIALYSIS
IL53072D0 Antibiotic formulation containing clindamycin for the treatment of bovine mastitis
IL52686D0 Electrodialysis process for the separation of essential amino acids from derivatives thereof
IL52687D0 Electrodialysis process for the separation of non-essential amino acids from derivatives thereof
DE2627113A1 Controlled release gelatin capsules - in which the gelatin shell is insolubilized with a crosslinking agent
IL49675D0 Method and apparatus for the performance of selective electro-dialysis
IL47468D0 Process for the cross-linking of proteins using water soluble cross-linking agents
IL46178D0 Method for the performance of enzymatic reactions